These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 3934860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH, Masoodi SR, Laway BA, Wani AI, Bashir MI.
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Long-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy--results of a one-year double blind study].
    Lundershausen R, Orban S, Pissarek D, Panzram G.
    Wien Klin Wochenschr; 1987 Sep 11; 99(17):603-8. PubMed ID: 3118579
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y, Oba K, Futami-Suda S, Norose J, Yasuoka H, Suzuki K, Ouchi M, Watanabe K, Suzuki T, Nakano H.
    Geriatr Gerontol Int; 2008 Sep 11; 8(3):160-5. PubMed ID: 18821999
    [Abstract] [Full Text] [Related]

  • 8. [Transdermal administration of insulin in type II diabetics. Results of a clinical pilot study].
    Liedtke RK, Sorger M, Merk F, Vetter H.
    Arzneimittelforschung; 1990 Aug 11; 40(8):884-6. PubMed ID: 2242080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The psychological aspects of diabetics with the secondary failure of sulfonylurea therapy].
    Ratzmann KP.
    Dtsch Med Wochenschr; 1991 Jan 18; 116(3):87-90. PubMed ID: 1898878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of the effect and tolerability of two glibenclamide preparations with different release rates].
    Schlich D, Lichtenberger K, Klingmann I, Pabst G, Jaeger H.
    Arzneimittelforschung; 1990 Oct 18; 40(10):1102-5. PubMed ID: 2127178
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P, Oksala H, Pitkäjärvi T.
    Arzneimittelforschung; 1985 Oct 18; 35(10):1596-9. PubMed ID: 3935120
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of newly diagnosed type II diabetic patients with special reference to prescribing glibenclamide in low doses].
    Häntzschel U, Wurlitzer M, Hanisch R, Bothe E, Dempe A.
    Z Gesamte Inn Med; 1989 Mar 01; 44(5):137-43. PubMed ID: 2496531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.